SCHEMBL5800280

SCHEMBL5800280

CCOC(=O)Cc1ccncc1F

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 1/20 0.51
LOXL2 Q9Y4K0 1/20 0.46
PKM P14618 1/20 0.41
TBXAS1 P24557 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40
HPGD P15428 2/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
GAA P10253 1/20 0.40
ALOX15 P16050 1/20 0.40
CASP1 P29466 1/20 0.40
CASP7 P55210 1/20 0.40
HSD17B10 Q99714 1/20 0.40
DPP4 P27487 2/20 0.39
KMT2A Q03164 2/20 0.38
TDP1 Q9NUW8 1/20 0.38
NLRP3 Q96P20 1/20 0.38
MEN1 O00255 1/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23579599 0.85 CYP4F2 (0.50) NAMPTLOXL2TBXAS1HPGDKDM4E
SCHEMBL8580162 0.84 PKM (0.43) NAMPTPKMTBXAS1SMN1; SMN2HSD17B10
SCHEMBL21855464 0.81 PKM (0.41) NAMPTPKMTBXAS1SMN1; SMN2HSD17B10
SCHEMBL5894021 0.81 AOC1 (0.47) PKMTBXAS1L3MBTL1SMN1; SMN2KDM4E
SCHEMBL3587236 0.81 PKM (0.43) PKMTBXAS1SMN1; SMN2ALDH1A1HSD17B10
SCHEMBL21855487 0.79 CYP4F2 (0.50) PKMTBXAS1SMN1; SMN2ALDH1A1GAA
SCHEMBL5893962 0.78 MAPK1 (0.47) PKMSMN1; SMN2KDM4EALDH1A1GAA
SCHEMBL17377024 0.78 MAPT (0.49) PKMTBXAS1L3MBTL1SMN1; SMN2HPGD
SCHEMBL513027 0.77 L3MBTL1 (0.60) PKML3MBTL1SMN1; SMN2HPGDKDM4E
SCHEMBL31053374 0.77 L3MBTL1 (0.60) PKML3MBTL1SMN1; SMN2HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1655296-A1 Thrombin inhibitors Graffinity Pharmaceuticals AG (DE) 2006-05-10 EP disclosed
WO-2006045459-A1 THROMBIN INHIBITORS SANTHERA PHARMACEUTICALS (SCHWEIZ) AG (CH) 2006-05-04 WO disclosed